v3 Template
C

Corbus Pharmaceuticals Holdings Inc.

Pharmaceuticals / Biotechnology Norwood, Massachusetts ~90 employees
Founded
--
Employees (Est.)
~90
6 leaders known
Total Funding
$251.7M
Funding Rounds
3
Last Funding
2025-10-31

About Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings, Inc. is dedicated to advancing innovative treatments for cancer and obesity. Committed to cutting-edge drug development and scientific excellence, the company focuses on creating impactful therapies to improve patient outcomes through purposeful research and compassionate care.

Products & Services

CRB-701 Cancer Treatment:A Nectin-4 targeted treatment for cancer, aimed at improving outcomes in oncology.
CRB-601 Cancer Treatment:A therapy targeting solid tumor cancers, designed to enhance patient prognosis.
CRB-913 Obesity Treatment:An inverse agonist biology-based treatment for obesity, focusing on sustainable health benefits.

Specialties

Oncology Treatments Obesity and Metabolic Disease Treatments Drug Development Clinical Research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 75000000
MR: -
FA: approximately $75 million
FAN: 75000000
D: 2025-10-31
FD: 2025-10-31
4 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 94500000
MR: -
FA: $94.5 million
FAN: 94500000
D: 2024-02-02
FD: 2024-02-02
3 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 82200000
MR: -
FA: approximately $82.2 million
FAN: 82200000
D: 2024-01-31
FD: 2024-01-31
3 investors
Public Offering Latest
2025-10-31
$75.0M
4 investors (Pro only)
Public Offering 2024-02-02
$94.5M
Public Offering 2024-01-31
$82.2M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Y

Yuval Cohen

Chief Executive Officer and Director

LinkedIn (Pro only)
S

Sean Moran

Chief Financial Officer

LinkedIn (Pro only)
D

Dominic Smethurst

Chief Medical Officer

LinkedIn (Pro only)
I

Ian Hodgson

Chief Operating Officer

C

Christina Bertsch

VP of Human Resources

G

G. Scott Goeken

General Counsel & Corporate Secretary

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

Corbus Pharmaceuticals Holdings Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Biotechnology
Company Size
~90 employees (est.)
Locations
Norwood, Massachusetts

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro